title: The impact of novel tests for tuberculosis depends on the diagnostic cascade.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Amanda Y
authors.initials: AY
authors.lastname: Sun
authors.affiliation: Foundation for Innovative New Diagnostics, Geneva, Switzerland Beth Israel Deaconess Medical Center, Boston, MA, USA.
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Denkinger
authors.affiliation: Dept of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA ddowdy@jhsph.edu.
authors.forename: David W
authors.initials: DW
authors.lastname: Dowdy
mesh_terms: D003140:Communicable Disease Control / Q000379:methods*; D003955:Diagnostic Tests, Routine / Q000379:methods*; D015658:HIV Infections / Q000150:complications; D006297:Health Services Accessibility; D006801:Humans; D007194:India; D008403:Mass Screening / Q000379:methods; D008962:Models, Theoretical; D012680:Sensitivity and Specificity; D014376:Tuberculosis / Q000175:diagnosis* / Q000503:physiopathology* / Q000635:transmission